Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Users Online: 69 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Sodium glucose co-transporter inhibitors – A new class of old drugs

Malhotra Aneeta, Kudyar Surbhi, Gupta Anil K, Kudyar Rattan P, Malhotra Pavan

Year : 2015| Volume: 5| Issue : 3 | Page no: 161-163

   This article has been cited by
1 SGLT -2 inhibitors and the risk of hospitalization for community-acquired pneumonia: A population-based cohort study
Vanessa C. Brunetti,Pauline Reynier,Laurent Azoulay,Oriana Hoi Yun Yu,Pierre Ernst,Robert W. Platt,Kristian B. Filion
Pharmacoepidemiology and Drug Safety. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Fundamentals about onset and progressive disease character of type 2 diabetes mellitus
Rob NM Weijers
World Journal of Diabetes. 2020; 11(5): 165
[Pubmed]  [Google Scholar] [DOI]
3 Cu II and Au III Complexes with Glycoconjugated Dithiocarbamato Ligands for Potential Applications in Targeted Chemotherapy
Nicoḷ Pettenuzzo,Leonardo Brustolin,Elisa Coltri,Alberto Gambalunga,Federica Chiara,Andrea Trevisan,Barbara Biondi,Chiara Nardon,Dolores Fregona
ChemMedChem. 2019;
[Pubmed]  [Google Scholar] [DOI]
4 Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat
Chih-Chao Yang,Yen-Ta Chen,Christopher Glenn Wallace,Kuan-Hung Chen,Ben-Chung Cheng,Pei-Hsun Sung,Yi-Chen Li,Sheung-Fat Ko,Hsueh-Wen Chang,Hon-Kan Yip
Biomedicine & Pharmacotherapy. 2019; 109: 658
[Pubmed]  [Google Scholar] [DOI]
5 Pharmacological aspects of the safety of gliflozins
Jean-Luc Faillie
Pharmacological Research. 2016;
[Pubmed]  [Google Scholar] [DOI]


Read this article